Tranche Update on Meta Biomed Co., Ltd.'s Equity Buyback Plan announced on October 29, 2018.
January 29, 2019 at 01:01 am EST
Share
From October 29, 2018 to December 31, 2018, the company has repurchased 164,000 shares, representing 0.7% for KRW 495.8 million. With this, the company has completed the repurchase of 164,000 shares, representing 0.7% for KRW 495.8 million under the buyback announced on October 29, 2018.
Meta Biomed Co., Ltd. is a Korea-based company engaged in the manufacture of medical materials and equipment for biotechnology and dental areas. The Company mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. It also distributes dental-related products.
META BIOMED CO., LTD. 
